1.Clinical observation of combined use sodium ozagrel and ultrasonic therapy for acute cerebral infarction
Xiaojiang CHEN ; Xuebiao LIANG ; Yanzhen LI ; Xiaoyun YANG
Chinese Journal of Primary Medicine and Pharmacy 2009;16(9):1569-1570
Objective To observe the clinical effect of Ozagrel sodium with ultrasonic therapy in patients with acute cerebral infarction (ACI). Methods Eighty-three ACI patients were randomly divided into 2 groups: ultra-sortie therapy group(n=42) received Ozagrel sodium and ultrasonic therapy, whereas control group(n = 41) only ac-ecpted the Ozagrel sodium for injection. Both two groups were under conventional treatment. The level of laboratory in-dex and the neurological impairment were detected before and after treatment. And the clinical effect were detected in the end of the treatment. Results The neurological impairment and the clinical effect defected after therapy in both groups, had statistical difference(P < 0. 05), especially in the ultrasonic therapy group. Conclusion Ozagrel sodium with ultrasonic therapy in patients with ACI could promote recovery of the neurological function, thus increase clinical effect.
2.Detection of autoimmune antibody in patients with SLE after autologous hematopoietic stem cell transplantation
Jianhua LI ; Jing SUN ; Xuebiao PENG ; Dan XU ; Ledong SUN ; Liang HUANG ; Fanyi MENG ; Jie ZHAO ; Kang ZENG
Journal of Chinese Physician 2002;0(S1):-
Objective To study changes of the autoimmune antibody level in patients after autologous hematopoietic stem cell transplantation(CD_(34)~+).Methods Twelve patients with SLE received autologous hematopoietic stem cell transplantation.All they survived and their immune system were recoverd after a period of time.The serum autoimmune antibody levels were measured before and after the transplantation,Results The antibody levels became normal 6 months after transplantation.Conclusion Autologous hematopoietic stem cell transplantation can effectively reduces the level of autoimmune antibody in patients with SLE.